» Articles » PMID: 36551232

Role of Pyroptosis in Intervertebral Disc Degeneration and Its Therapeutic Implications

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Dec 23
PMID 36551232
Authors
Affiliations
Soon will be listed here.
Abstract

Intervertebral disc degeneration (IDD), a progressive and multifactorial pathological process, is predominantly associated with low back pain and permanent disability. Pyroptosis is a type of lytic programmed cell death triggered by the activation of inflammasomes and caspases. Unlike apoptosis, pyroptosis is characterized by the rupture of the plasma membrane and the release of inflammatory mediators, accelerating the destruction of the extracellular matrix (ECM). Recent studies have shown that pyrin domain-containing 3 (NLRP3) inflammasome-mediated pyroptosis in nucleus pulposus (NP) cells is activated in the progression of IDD. Furthermore, targeting pyroptosis in IDD demonstrates the excellent capacity of ECM remodeling and its anti-inflammatory properties, suggesting that pyroptosis is involved in the IDD process. In this review, we briefly summarize the molecular mechanism of pyroptosis and the pathogenesis of IDD. We also focus on the role of pyroptosis in the pathological progress of IDD and its targeted therapeutic application.

Citing Articles

Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration.

Zhu D, Wang Z, Chen S, Li Y, Kang X J Neuroinflammation. 2025; 22(1):13.

PMID: 39844302 PMC: 11755837. DOI: 10.1186/s12974-025-03335-4.


Targeting nucleus pulposus cell death in the treatment of intervertebral disc degeneration.

Sun H, Guo J, Xiong Z, Zhuang Y, Ning X, Liu M JOR Spine. 2024; 7(4):e70011.

PMID: 39703198 PMC: 11655182. DOI: 10.1002/jsp2.70011.


Exploration and breakthrough in the mode of intervertebral disc cell death may lead to significant advances in treatments for intervertebral disc degeneration.

Chen H, Tang T, Xue C, Liu X, Xi Z, Xie L J Orthop Surg Res. 2024; 19(1):825.

PMID: 39639370 PMC: 11619685. DOI: 10.1186/s13018-024-05280-z.


Single-cell sequencing reveals cellular heterogeneity of nucleus pulposus in intervertebral disc degeneration.

Jia S, Liu H, Yang T, Gao S, Li D, Zhang Z Sci Rep. 2024; 14(1):27245.

PMID: 39516278 PMC: 11549379. DOI: 10.1038/s41598-024-78675-x.


Discogenic Low Back Pain: Anatomic and Pathophysiologic Characterization, Clinical Evaluation, Biomarkers, AI, and Treatment Options.

De Simone M, Choucha A, Ciaglia E, Conti V, Pecoraro G, Santurro A J Clin Med. 2024; 13(19).

PMID: 39407975 PMC: 11477864. DOI: 10.3390/jcm13195915.


References
1.
Boucher D, Monteleone M, Coll R, Chen K, Ross C, Teo J . Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J Exp Med. 2018; 215(3):827-840. PMC: 5839769. DOI: 10.1084/jem.20172222. View

2.
Johnson W, Sivan S, Wright K, Eisenstein S, Maroudas A, Roberts S . Human intervertebral disc cells promote nerve growth over substrata of human intervertebral disc aggrecan. Spine (Phila Pa 1976). 2006; 31(11):1187-93. DOI: 10.1097/01.brs.0000217669.04903.61. View

3.
Chen F, Jiang G, Liu H, Li Z, Pei Y, Wang H . Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop. Bone Res. 2020; 8:10. PMC: 7028926. DOI: 10.1038/s41413-020-0087-2. View

4.
Yang H, Wang H, Andersson U . Targeting Inflammation Driven by HMGB1. Front Immunol. 2020; 11:484. PMC: 7099994. DOI: 10.3389/fimmu.2020.00484. View

5.
Ruhl S, Shkarina K, Demarco B, Heilig R, Santos J, Broz P . ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018; 362(6417):956-960. DOI: 10.1126/science.aar7607. View